National PBM Monograph Template

Data with rivaroxaban in the treatment of VTE is limited to the population studied in the EINSTEIN clinical program and for a duration of about 200 days in the acute setting and about 190 days in the extended treatment setting. The 2012 Chest Guidelines provide a weak recommendation (Grade 2C) favoring the use of VKA and LMWH over the newer ... ................
................